These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19656478)

  • 1. Intranasal corticosteroids: do they improve ocular allergy?
    Origlieri C; Bielory L
    Curr Allergy Asthma Rep; 2009 Jul; 9(4):304-10. PubMed ID: 19656478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal corticosteroids and allergic rhinoconjunctivitis.
    Origlieri C; Bielory L
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):450-6. PubMed ID: 18769200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should intranasal corticosteroids be used for the treatment of ocular symptoms of allergic rhinoconjunctivitis? A review of their efficacy and safety profile.
    Lightman S; Scadding GK
    Int Arch Allergy Immunol; 2012; 158(4):317-25. PubMed ID: 22488416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal corticosteroids and the eye: from negative ocular effects to clinical efficacy as a class effect.
    Bielory L
    Ann Allergy Asthma Immunol; 2008 May; 100(5):506-8. PubMed ID: 18517085
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge.
    Lanier BQ; Abelson MB; Berger WE; Granet DB; D'Arienzo PA; Spangler DL; Kägi MK
    Clin Ther; 2002 Jul; 24(7):1161-74. PubMed ID: 12182260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids.
    Blaiss MS
    Curr Med Res Opin; 2008 Mar; 24(3):821-36. PubMed ID: 18257976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intranasal corticosteroids for the ocular symptoms of allergic rhinitis: A systematic review.
    Hong J; Bielory B; Rosenberg JL; Bielory L
    Allergy Asthma Proc; 2011; 32(1):22-35. PubMed ID: 21262095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate.
    Bielory L
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):272-9. PubMed ID: 18434976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
    Crampton HJ
    Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic conjunctivitis and the impact of allergic rhinitis.
    Bielory L
    Curr Allergy Asthma Rep; 2010 Mar; 10(2):122-34. PubMed ID: 20425504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allergic rhinoconjunctivitis and immunotherapy: an update].
    Leimgruber A; Spertini F
    Rev Med Suisse; 2009 Jan; 5(186):88-93. PubMed ID: 19238924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic treatment of pollen-related allergic rhinoconjunctivitis in children: randomized controlled trial.
    Wartna JB; Bohnen AM; Elshout G; Pijnenburg MW; Pols DH; Gerth van Wijk RR; Bindels PJ
    Allergy; 2017 Apr; 72(4):636-644. PubMed ID: 27696447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seasonal and Perennial Allergic Rhinoconjunctivitis].
    Schröder K; Finis D; Meller S; Buhren BA; Wagenmann M; Geerling G
    Laryngorhinootologie; 2017 Feb; 96(2):89-97. PubMed ID: 28291999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic rhinoconjunctivitis in the Australian population: burden of disease and attitudes to intranasal corticosteroid treatment.
    Katelaris CH; Sacks R; Theron PN
    Am J Rhinol Allergy; 2013; 27(6):506-9. PubMed ID: 24274227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?
    Keith PK; Scadding GK
    Curr Med Res Opin; 2009 Aug; 25(8):2021-41. PubMed ID: 19569975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model.
    Crampton HJ
    Clin Ther; 2002 Nov; 24(11):1800-8. PubMed ID: 12501875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for the management of perennial allergic rhinitis, with a focus on intranasal corticosteroids.
    Brunton SA; Fromer LM
    South Med J; 2007 Jul; 100(7):701-8. PubMed ID: 17639750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of intranasal antihistamines in the treatment of allergic rhinitis.
    Kaliner MA; Berger WE; Ratner PH; Siegel CJ
    Ann Allergy Asthma Immunol; 2011 Feb; 106(2 Suppl):S6-S11. PubMed ID: 21277531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.